SCHEMBL22178472

SCHEMBL22178472

Cc1cccc2c1c1c3c4ccccc4n4c5cccc(C)c5c(c5c6ccccc6n2c51)c34

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ALKBH5 Q6P6C2 1/20 0.46
FTO Q9C0B1 1/20 0.46
CYP2A6 P11509 2/20 0.38
CYP1A2 P05177 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
GPR3 P46089 1/20 0.34
CHEK1 O14757 1/20 0.34
RAB9A P51151 3/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
IDO1 P14902 1/20 0.34
MAPK1 P28482 1/20 0.34
MDM2 Q00987 1/20 0.34
MCL1 Q07820 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21570098 0.82 KDM4E (0.43) MAPTKDM4EALKBH5FTOCYP1A2
SCHEMBL16621616 0.81 ALKBH5 (0.55) MAPTKDM4EALKBH5FTOCYP2A6
SCHEMBL24601592 0.78 CYP1A2 (0.38) MAPTKDM4EALKBH5FTOCYP2A6
SCHEMBL24601748 0.78 KDM4E (0.33) MAPTKDM4EALKBH5FTOCYP1A2
SCHEMBL19114299 0.76 ALKBH5 (0.45) MAPTKDM4EALKBH5FTOCYP2A6
SCHEMBL24601438 0.76 ALKBH5 (0.41) MAPTKDM4EALKBH5FTOCYP2A6
SCHEMBL16621619 0.76 KDM4E (0.59) MAPTKDM4EALKBH5FTOCYP1A2
SCHEMBL24601589 0.75 HSD17B10 (0.36) MAPTKDM4ECYP2A6ALDH1A1MEN1
SCHEMBL24601632 0.75 ALKBH5 (0.44) MAPTKDM4EALKBH5FTOCYP2A6
SCHEMBL24601620 0.75 ALKBH5 (0.44) MAPTKDM4EALKBH5FTOCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200212315-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212315-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND OR10J3, ESR1, NFE2L2 MAPT 3295/4885KDM4E 2780/4885ALKBH5 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.